| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥4.32B | -15.2% |
| Gross profit | ¥3.22B | — |
| Operating income | ¥1.84B | — |
| Net income | ¥1.38B | -15.8% |
| Gross margin | 74.4% | Net margin 32.0% |
| Revenue Q/Q | +232.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.11B | 25.6% |
| R&D | ¥0.01B | 0.2% |
| SG&A | ¥0.73B | 16.9% |
| Tax & other | ¥0.45B | 10.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新 ・ 洛阳钼业 ・ 德业股份 ・ 东鹏饮料 ・ 澜起科技 ・ 中国通号 ・ 中微公司 ・ 传音控股
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies